# Remote Rapid Onsite Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA)

> **NCT05962944** · — · COMPLETED · sponsor: **Royal Cornwall Hospitals Trust** · enrollment: 25 (actual)

## Conditions studied

- Head and Neck Neoplasms

## Interventions

- **DEVICE:** Olympus Cellsens software

## Key facts

- **NCT ID:** NCT05962944
- **Lead sponsor:** Royal Cornwall Hospitals Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-25
- **Primary completion:** 2023-06-15
- **Final completion:** 2023-07-24
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05962944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05962944, "Remote Rapid Onsite Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA)". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05962944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*